Cita APA

Singh, R. S. P., Pradhan, V., Roberts, E. S., Scaramozza, M., Kieras, E., Gale, J. D., . . . Tehlirian, C. (2020). Safety and Pharmacokinetics of the Oral TYK2 Inhibitor PF‐06826647: A Phase I, Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Escalation Study. Clin Transl Sci.

Citación estilo Chicago

Singh, Ravi Shankar P., et al. "Safety and Pharmacokinetics of the Oral TYK2 Inhibitor PF‐06826647: A Phase I, Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Escalation Study." Clin Transl Sci 2020.

Cita MLA

Singh, Ravi Shankar P., et al. "Safety and Pharmacokinetics of the Oral TYK2 Inhibitor PF‐06826647: A Phase I, Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Escalation Study." Clin Transl Sci 2020.